Inorganic Radiopharmaceuticals: Famous Products & Pricelist Overview

As a leader in Inorganic Radiopharmaceuticals, I understand the critical importance of quality and compliance in our industry. Our products not only meet but exceed CE Certification standards, ensuring safety and efficacy for all your healthcare needs. We take pride in offering a comprehensive pricelist that reflects our commitment to affordability without compromising quality, At Sichuan Longevous Beamtech Co., Ltd., we partner with several reputable factories that uphold stringent manufacturing processes, guaranteeing the highest quality in every batch. I am here to support you in sourcing the best radiopharmaceuticals that meet your specific requirements. Don't hesitate to reach out for more details on our product range or if you need assistance with your orders. Together, we can enhance patient care with cutting-edge solutions that truly make a difference

Hot Selling Product

High Current Solid Target Station

Cyclotron LB-20

LBT Gas Target System

IsotopeX Lab

X-Tracer Synth-FDG 1.1

Don't Miss These Inorganic Radiopharmaceuticals Ahead of the Curve Service

In the ever-evolving field of nuclear medicine, the demand for innovative radiopharmaceuticals is continuously growing. As healthcare professionals strive to enhance diagnostic accuracy and treatment efficacy, inorganic radiopharmaceuticals are at the forefront of this transformation. These advanced compounds not only provide superior imaging capabilities but also promise higher precision in targeted therapies, driving better patient outcomes. With ongoing advancements in research and development, it's crucial for global procurement partners to stay informed about the latest offerings in this sector. The integration of sophisticated technology in the production of inorganic radiopharmaceuticals has resulted in products that meet the highest quality standards. By leveraging state-of-the-art manufacturing processes, these compounds ensure reliability and consistency, which are vital in clinical settings. As a prospective global partner, investing in these cutting-edge solutions can position your organization ahead of the curve in this competitive market. The ability to deliver precise diagnostic and therapeutic tools will not only enhance clinical outcomes but also elevate the overall patient experience. Looking ahead, the landscape of nuclear medicine is set to expand, with new developments and applications emerging regularly. Engaging with suppliers who prioritize innovation and excellence in radiopharmaceuticals can significantly benefit your procurement strategy. By exploring partnerships focused on inorganic solutions, your organization can ensure access to the latest advancements that cater to the evolving needs of the healthcare industry. Don’t miss out on the opportunity to lead in this dynamic market; aligning with pioneering suppliers can be a game-changer for your business.

Don't Miss These Inorganic Radiopharmaceuticals Ahead of the Curve Service

Radiopharmaceutical	Main Use	Half-Life	Common Isotopes	Administration Route
Sodium Iodide (I-131)	Thyroid cancer treatment	8 days	I-131	Oral
Technetium-99m	Bone imaging	6 hours	Tc-99m	Intravenous
Gallium-67	Tumor detection	78 hours	Ga-67	Intravenous
Thallium-201	Cardiac imaging	73 hours	Tl-201	Intravenous
Radioactive Phosphorus (P-32)	Bone pain relief	14.3 days	P-32	Intravenous/Solid

Trends in Inorganic Radiopharmaceutical Usage Over the Years

The chart above illustrates the trends in the usage of inorganic radiopharmaceuticals from 2019 to 2023. Over the years, there has been a noticeable increase in the number of doses administered, reflecting a growing acceptance and application of these therapeutics in various medical practices. In 2019, the usage was around 150,000 doses, which rose significantly to 500,000 doses by 2023. This upward trend suggests that healthcare providers are increasingly relying on these radiopharmaceuticals for diagnostic and therapeutic purposes, possibly due to advancements in technology and an expanding body of evidence supporting their efficacy. The growth can also be attributed to an overall increase in patient care demands and the need for precise imaging techniques in diagnosing complex conditions. As the field continues to evolve, it is essential for stakeholders to stay informed about these trends and their implications for the future of medicine.